SLBT

distress 6/10 · elevated risk

$3.18-5%today-75% from 52w high

sl-bio.comTaipei, TaiwanBiotechnology

Revenue

pre-revenue

Liquidity

$1M

Runway

0.7 yrs

Shares 1y

—

Price & events

-69.9% over 6M

CatalystRating changeDilutionFinancingdashed = today

-4.9%

-26.6%

-19.7%

-61.2%

-69.9%

-69.0%

—

-68.3%

All

Overview

Volume: 71.03K
52 Week Range: $3.18 – $12.81
Short %: 0.01%
% Held by Insiders: 59.55%
% Held by Institutions: 0.39%
RVOL: 0.05x

Pipeline · 0 trials · 0 upcoming

Readout	Phase	Drug	Indication	Enroll	Status
No pipeline trials tracked.

Catalyst news & presentations · 0

No catalyst news yet.

Approved drugs (0)

none — clinical-stage

Capital structure — dilution & financing

Shares out: — · 1 offerings/1y · 0 PIPEs

2026-01-13424B3offering
2026-01-13EFFECTshelf_effective

🔒 Positioning — Pro

Short interest / days-to-cover, insider buys & sells.

Upgrade to Pro

🔒 Top holders — Pro

Institutional ownership + quarter-over-quarter accumulation/trimming.

Upgrade to Pro

Wall St ratings

no consensus

no recent rating changes

Competitors

none identified